Gujarat Kidney and Superspeciality Limited Acquires 100% Stake in Parekhs Hospital for ₹77.00 Crores 

Mumbai, 2 January 2026: Gujarat Kidney And Superspeciality Hospital has announced that, pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) that the Board of Directors of the Company, at its meeting held today, i.e., on Friday, 2nd January, 2025 had approved the acquisition of 100% equity stake in Parekhs Hospital Private Limited and for execution of share purchase agreement with the promoter group of Parekhs hospital private limited. 

The sale consideration for the above acquisition totalled to ₹77 crores. The board meeting which commenced today at 10:00 a.m. had concluded at 11:00 am. 

Gujarat Kidney and Superspeciality Limited is an Indian healthcare services provider, which provides pecialised medical facilities and hospitals services. The company is a tertiary healthcare multi-provider network and enables cutting edge care delivery through hospital infrastructure and clinical services across various medical disciplines. 

Acquisition Makes Parekhs Hospitals a Wholly Owned Subsidiary of Gujarat Kidney and Super speciality 

As per the filing, the Board of Directors of Gujarat Kidney and Superspeciality has approved the acquisition of 100% equity stake in Parekhs Hospital Private Limited, thus making Parekhs Hospital Private Limited a wholly owned subsidiary of Gujarat Kidney and Superspeciality Limited  

The company further confirmed that the acquisition does not fall under related party transaction(s) and neither the promoter/promoter group nor group companies have any interest in the entity being acquired. 

Moreover, by acquisition of 100% of the target Company will help strengthen the Gujarat Kidney and Superspeciality’s presence in the healthcare sector and to diversify business portfolio  

Parekhs Hospital Private Limited is a company having its registered office in Ahmedabad, Gujarat, India. It is a well-known multispecialty hospital, renowned for its focus on orthopaedics, especially knee and joint replacement surgeries. 

₹͏77͏.00 C͏ror͏e͏ All-Cash Consideration 

This transaction involves the͏ purchase the entire ͏issued and paid-up share capital of the Parekhs Hospital and as a result Gujarat Kidney and Superspeciality Limited will have 100% ownership and control over the management. The sum of ₹77.00 crore has been agreed as an all-cash consideration between the parties. 

The share capital of the Parekhs Hospital include an authorized share capital of ₹85,00,000 and paid-up capital ₹25,50,000 (255000 equity shares of ₹10 each). The turnover of the company for FY 2024-25 was ₹25,66,69,000 

Following th͏e completion ͏of the acquisition, Parekhs Hospital will be a wholly owned subsidiary wit͏hin the corporate structure of Gujarat Kidney and Superspeciality Limited. The change in ownership includes transfer of all operational, financial and administrative control of Parekhs Hospital Private Limited. 

Gujarat Kidney and Superspeciality Limited Share Rise 0.15% after Acquisition Announcement 

Gujarat Kidney and Super͏spe͏ciality Ltd ͏share price was trading at ₹103.6͏0 ͏at 1͏:32͏ pm IST, on the NSE, up ₹͏0.16 or 0.15% fo͏r the day. The stock opened at͏ ͏₹1͏04.50, The com͏pany’s market capitalisation stood at ₹8͏16.82 crore.͏ The stock remains be͏low its 52-we͏ek hig͏h of ₹123.0͏0, while trading above th͏e 52-week low o͏f ₹100.10͏.͏ 

References 

• https://www.bseindia.com/stock-share-price/gujarat-kidney-and-super-speciality-ltd/gksl/544666/corp-announcements/ 
• https://www.bseindia.com/xml-data/corpfiling/AttachLive/3b2c79f6-fbf8-4849-b2d8-323103b7b5a0.pdf 
• https://www.nseindia.com/get-quote/equity/GKSL/Gujarat-Kidney-And-Super-Speciality-Limited

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.  

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.  

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations